CRVS – corvus pharmaceuticals, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CRVS

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

10/14

07:57 am

crvs

Corvus Pharmaceuticals (NASDAQ:CRVS) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.

Low Report

Corvus Pharmaceuticals (NASDAQ:CRVS) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.

Report

10/13

08:02 am

crvs

Rating for CRVS

Low Report

Rating for CRVS

Report

10/13

08:02 am

crvs

Rating for CRVS

Low Report

Rating for CRVS

Report

10/13

05:25 am

crvs

Corvus Pharmaceuticals initiated with an Overweight at Barclays

Report

Corvus Pharmaceuticals initiated with an Overweight at Barclays

Report

10/13

05:25 am

crvs

Corvus Pharmaceuticals initiated with an Overweight at Barclays

Report

Corvus Pharmaceuticals initiated with an Overweight at Barclays

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.